Announce Date | 04/24/2025 |
EPS Normalized Actual | $0.02 (Beat by $0.04) |
EPS GAAP Actual | $0.02 (Beat by $0.04) |
Revenue Actual | $10.431B |
Revenue Surprise | Beat by $10431M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.12865 |
EPS GAAP Estimate | $1.12865 |
Revenue Estimate | $11.792871633B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 5.24 | 5.42 | 5.10409 | 5.4909 | 1 |
Dec 2026 | 4.65776 | 6.1 | 4.20251 | 5.31 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | -0.44 | -1.42533 | 10.431B | -3.2% | -953.12M |
FQ4 2024 (Dec 2024) | -0.14 | -0.14 | 10.621B | -11.66% | 10621M |
FQ3 2024 (Sep 2024) | 0.46 | 0.46 | 10.73B | 0% | 10730M |
FQ2 2024 (Jun 2024) | 0.62 | 0.62 | 10.915B | -4.63% | 10915M |
FQ1 2024 (Mar 2024) | 0.0312 | 0.0312 | 10.765B | -10.09% | 10765M |
FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 11.859B | 0% | 11859M |
FQ3 2023 (Sep 2023) | 0.43 | 0.43 | 10.73B | -31.55% | 10730M |
FQ2 2023 (Jun 2023) | 0.68 | 0.68 | 11.42B | -37.16% | 11420M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.12865
Consensus Revenue Estimates
11.792871633B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.89718 | -- | 0.88506 | 0.91106 | 4 |
FQ2 2027 (Jun 2027) | 0.84098 | -- | 0.82962 | 0.85399 | 3 |
FQ1 2027 (Mar 2027) | 0.7153 | -- | 0.70565 | 0.72638 | 4 |
FQ4 2026 (Oct 2026) | 1.33434 | -- | 1.25193 | 1.42997 | 9 |
FQ3 2026 (Jul 2026) | 1.27486 | -- | 1.19612 | 1.36623 | 9 |
FQ2 2026 (Jun 2026) | 1.28555 | -- | 1.22113 | 1.33631 | 9 |
FQ1 2026 (Mar 2026) | 1.02481 | 142.93 | 0.97345 | 1.06527 | 9 |
FQ4 2025 (Oct 2025) | 1.20505 | 111.62 | 1.13062 | 1.29142 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 12.41B | -- | 12.28B | 12.56B | 2 |
FQ2 2027 (Jun 2027) | 12.07B | -- | 11.94B | 12.21B | 2 |
FQ1 2027 (Mar 2027) | 11.34B | -- | 11.22B | 11.47B | 2 |
FQ4 2026 (Oct 2026) | 13.04B | -- | 12.42B | 13.76B | 4 |
FQ3 2026 (Jul 2026) | 12.55B | -- | 11.96B | 13.25B | 4 |
FQ2 2026 (Jun 2026) | 13.48B | -- | 12.96B | 13.89B | 4 |
FQ1 2026 (Mar 2026) | 12.19B | 14.46 | 11.72B | 12.56B | 7 |
FQ4 2025 (Oct 2025) | 12.28B | 13.52 | 11.7B | 12.96B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.98533 | -0.44 | -1.42533 | 323.94% |
FQ4 2024 (Dec 2024) | -0.14 | -0.14 | 100% | |
FQ3 2024 (Sep 2024) | 0.46 | 0.46 | 100% | |
FQ2 2024 (Jun 2024) | 0.62 | 0.62 | 100% | |
FQ1 2024 (Mar 2024) | 0.0312 | 0.0312 | 100% | |
FQ4 2023 (Dec 2023) | 0.91 | 0.91 | 100% | |
FQ3 2023 (Sep 2023) | 0.43 | 0.43 | 100% | |
FQ2 2023 (Jun 2023) | 0.68 | 0.68 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $11.38B | $10.43B | $-953.12M | -9.14% |
FQ4 2024 (Dec 2024) | $0B | $10.62B | $10621M | 100% |
FQ3 2024 (Sep 2024) | $0B | $10.73B | $10730M | 100% |
FQ2 2024 (Jun 2024) | $0B | $10.92B | $10915M | 100% |
FQ1 2024 (Mar 2024) | $0B | $10.77B | $10765M | 100% |
FQ4 2023 (Dec 2023) | $0B | $11.86B | $11859M | 100% |
FQ3 2023 (Sep 2023) | $0B | $10.73B | $10730M | 100% |
FQ2 2023 (Jun 2023) | $0B | $11.42B | $11420M | 100% |